Professor Stephen Parente was quoted in an Oct. 23rd StarTribune article about Biovest's custom vaccine for two types of cancer which could have a sizable target market, and a sizable price tag.
Main navigation | Main content
Monday, October 24, 2011
Professor Stephen Parente was quoted in an Oct. 23rd StarTribune article about Biovest's custom vaccine for two types of cancer which could have a sizable target market, and a sizable price tag.